PureTech Health plc Logo

PureTech Health plc

A clinical-stage biotherapeutics company developing new medicines for devastating diseases.

PRTC | IL

Overview

Corporate Details

ISIN(s):
GB00BPVG5C82 (+2 more)
LEI:
213800LVPDNO2Z9T9I39
Country:
United States of America
Address:
6 TIDE STREET, 2210 BOSTON

Description

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-09-06 08:00
PRTC's Vor Shares New AML Data Validating Approach
English 24.6 KB
2024-08-28 08:01
Half-year Report
English 529.3 KB
2024-08-28 08:00
Results of AGM on 13 June 2024 – Update Statement
English 12.3 KB
2024-08-22 08:00
PRTC Adds Industry Leader to Board of Directors
English 15.8 KB
2024-08-21 08:00
Notice of Results
English 9.5 KB
2024-08-13 13:05
PRTC's Seaport Appoints Global Pharma Exec to BOD
English 17.6 KB
2024-07-23 13:05
PRTC'S Vedanta Expands Leadership Team
English 17.8 KB
2024-07-01 18:00
Holding(s) in Company
English 23.4 KB
2024-06-27 18:01
PDMR Notification RSU Vesting
English 24.3 KB
2024-06-27 18:00
Director/PDMR Shareholding
English 20.2 KB
2024-06-24 18:00
Completion of Tender Offer & Total Voting Rights
English 20.6 KB
2024-06-24 08:00
Result of Tender Offer
English 24.5 KB
2024-06-20 08:00
Director Declaration
English 13.5 KB
2024-06-18 13:05
PRTC's Seaport Appoints Seasoned Execs to Team
English 23.9 KB
2024-06-13 18:42
Result of AGM
English 33.3 KB

Automate Your Workflow. Get a real-time feed of all PureTech Health plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PureTech Health plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PureTech Health plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.